149 related articles for article (PubMed ID: 32564236)
21. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial.
Park JW; Kang SB; Hao J; Lim SB; Choi HS; Kim DW; Chang HJ; Kim DY; Jung KH; Kim TY; Kang GH; Chie EK; Kim SY; Sohn DK; Kim JS; Lee HS; Kim JH; Jeong SY; Oh JH
Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):569-577. PubMed ID: 33894918
[TBL] [Abstract][Full Text] [Related]
22. Frequency of Sarcopenia, Sarcopenic Obesity, and Changes in Physical Function in Surgical Oncology Patients Referred for Prehabilitation.
Ngo-Huang A; Herbert A; Fontillas RC; Parker NH; Asumbrado R; Garg N; Dibaj S; Liu DD; Ng AH; Guo Y; Shin KY; Katz MHG; Bruera E
Integr Cancer Ther; 2021; 20():15347354211000118. PubMed ID: 33829906
[TBL] [Abstract][Full Text] [Related]
23. The effect of a pre- and post-operative exercise programme versus standard care on physical fitness of patients with oesophageal and gastric cancer undergoing neoadjuvant treatment prior to surgery (The PERIOP-OG Trial): Study protocol for a randomised controlled trial.
Tully R; Loughney L; Bolger J; Sorensen J; McAnena O; Collins CG; Carroll PA; Arumugasamy M; Murphy TJ; Robb WB;
Trials; 2020 Jul; 21(1):638. PubMed ID: 32660526
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.
Conroy T; Bosset JF; Etienne PL; Rio E; François É; Mesgouez-Nebout N; Vendrely V; Artignan X; Bouché O; Gargot D; Boige V; Bonichon-Lamichhane N; Louvet C; Morand C; de la Fouchardière C; Lamfichekh N; Juzyna B; Jouffroy-Zeller C; Rullier E; Marchal F; Gourgou S; Castan F; Borg C;
Lancet Oncol; 2021 May; 22(5):702-715. PubMed ID: 33862000
[TBL] [Abstract][Full Text] [Related]
25. Can sarcopenia predict complete response after total neoadjuvant therapy in advanced rectal cancer? A multicentre observational cohort study.
Bedrikovetski S; Traeger L; Price TJ; Carruthers S; Selva-Nayagam S; Moore JW; Sammour T
J Surg Oncol; 2023 Jul; 128(1):75-84. PubMed ID: 36971689
[TBL] [Abstract][Full Text] [Related]
26. Skeletal muscle wasting and long-term prognosis in patients undergoing rectal cancer surgery without neoadjuvant therapy.
Giani A; Famularo S; Fogliati A; Riva L; Tamini N; Ippolito D; Nespoli L; Braga M; Gianotti L
World J Surg Oncol; 2022 Feb; 20(1):51. PubMed ID: 35216606
[TBL] [Abstract][Full Text] [Related]
27. Effect of home-based prehabilitation on postoperative complications after surgery for gastric cancer: randomized clinical trial.
Bausys A; Luksta M; Anglickiene G; Maneikiene VV; Kryzauskas M; Rybakovas A; Dulskas A; Kuliavas J; Stratilatovas E; Macijauskiene L; Simbelyte T; Celutkiene J; Jamontaite IE; Cirtautas A; Lenickiene S; Petrauskiene D; Cikanaviciute E; Gaveliene E; Klimaviciute G; Rauduvyte K; Bausys R; Strupas K
Br J Surg; 2023 Nov; 110(12):1800-1807. PubMed ID: 37750588
[TBL] [Abstract][Full Text] [Related]
28. Feasibility and Preliminary Efficacy of a 10-Week Resistance and Aerobic Exercise Intervention During Neoadjuvant Chemoradiation Treatment in Rectal Cancer Patients.
Singh F; Galvão DA; Newton RU; Spry NA; Baker MK; Taaffe DR
Integr Cancer Ther; 2018 Sep; 17(3):952-959. PubMed ID: 29888608
[TBL] [Abstract][Full Text] [Related]
29. A randomised controlled trial to assess whether prehabilitation improves fitness in patients undergoing neoadjuvant treatment prior to oesophagogastric cancer surgery: study protocol.
Allen S; Brown V; Prabhu P; Scott M; Rockall T; Preston S; Sultan J
BMJ Open; 2018 Dec; 8(12):e023190. PubMed ID: 30580268
[TBL] [Abstract][Full Text] [Related]
30. The effects of prehabilitation on body composition in patients undergoing multimodal therapy for esophageal cancer.
Halliday LJ; Boshier PR; Doganay E; Wynter-Blyth V; Buckley JP; Moorthy K
Dis Esophagus; 2023 Jan; 36(2):. PubMed ID: 35795994
[TBL] [Abstract][Full Text] [Related]
31. A Phase I Study Examining the Feasibility and Safety of an Aerobic Exercise Intervention in Patients With Rectal Cancer During and After Neoadjuvant Chemoradiotherapy.
Morielli AR; Usmani N; Boulé NG; Tankel K; Severin D; Nijjar T; Joseph K; Courneya KS
Oncol Nurs Forum; 2016 May; 43(3):352-62. PubMed ID: 27105196
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the impact of psoas muscle index, a parameter of sarcopenia, in patients with esophageal squamous cell carcinoma receiving neoadjuvant therapy.
Ozawa Y; Nakano T; Taniyama Y; Sakurai T; Onodera Y; Kamiya K; Hikage M; Sato C; Takaya K; Konno T; Unno M; Kamei T
Esophagus; 2019 Oct; 16(4):345-351. PubMed ID: 30980203
[TBL] [Abstract][Full Text] [Related]
33. Effect of Multimodal Prehabilitation vs Postoperative Rehabilitation on 30-Day Postoperative Complications for Frail Patients Undergoing Resection of Colorectal Cancer: A Randomized Clinical Trial.
Carli F; Bousquet-Dion G; Awasthi R; Elsherbini N; Liberman S; Boutros M; Stein B; Charlebois P; Ghitulescu G; Morin N; Jagoe T; Scheede-Bergdahl C; Minnella EM; Fiore JF
JAMA Surg; 2020 Mar; 155(3):233-242. PubMed ID: 31968063
[TBL] [Abstract][Full Text] [Related]
34. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial.
Kang SB; Park JW; Jeong SY; Nam BH; Choi HS; Kim DW; Lim SB; Lee TG; Kim DY; Kim JS; Chang HJ; Lee HS; Kim SY; Jung KH; Hong YS; Kim JH; Sohn DK; Kim DH; Oh JH
Lancet Oncol; 2010 Jul; 11(7):637-45. PubMed ID: 20610322
[TBL] [Abstract][Full Text] [Related]
35. The effects of neoadjuvant chemoradiotherapy on physical fitness and morbidity in rectal cancer surgery patients.
West MA; Loughney L; Barben CP; Sripadam R; Kemp GJ; Grocott MP; Jack S
Eur J Surg Oncol; 2014 Nov; 40(11):1421-8. PubMed ID: 24784775
[TBL] [Abstract][Full Text] [Related]
36. Prehabilitation in rectal surgery: a narrative review.
Hannan E; Kelly ME; Fahy MR; Winter DC
Int J Colorectal Dis; 2022 Feb; 37(2):293-299. PubMed ID: 35006332
[TBL] [Abstract][Full Text] [Related]
37. Is radiological psoas muscle area measurement a predictor of postoperative complications after rectal resection for rectal cancer? A retrospective study.
Uehara H; Yamazaki T; Iwaya A; Kameyama H; Utsumi S; Harada R; Komatsu M; Hirai M; Kubota A; Katada T; Kobayashi K; Sato D; Yokoyama N; Kuwabara S; Otani T
Surg Today; 2022 Feb; 52(2):306-315. PubMed ID: 34309711
[TBL] [Abstract][Full Text] [Related]
38. Impact of preoperative change in physical function on postoperative recovery: argument supporting prehabilitation for colorectal surgery.
Mayo NE; Feldman L; Scott S; Zavorsky G; Kim DJ; Charlebois P; Stein B; Carli F
Surgery; 2011 Sep; 150(3):505-14. PubMed ID: 21878237
[TBL] [Abstract][Full Text] [Related]
39. Sarcopenia during neoadjuvant therapy for oesophageal cancer: characterising the impact on muscle strength and physical performance.
Guinan EM; Doyle SL; Bennett AE; O'Neill L; Gannon J; Elliott JA; O'Sullivan J; Reynolds JV; Hussey J
Support Care Cancer; 2018 May; 26(5):1569-1576. PubMed ID: 29197960
[TBL] [Abstract][Full Text] [Related]
40. Is sarcopenia a better predictor of complications than body mass index? Sarcopenia and surgical outcomes in patients with rectal cancer.
Jochum SB; Kistner M; Wood EH; Hoscheit M; Nowak L; Poirier J; Eberhardt JM; Saclarides TJ; Hayden DM
Colorectal Dis; 2019 Dec; 21(12):1372-1378. PubMed ID: 31276286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
